Adrenergic drugs
Adrenergic Agonists, Beta-Blockers, Inotropes and Vasopressors: FCPS Part 1
Alpha and beta receptors, sympathomimetics, alpha- and beta-blockers, inotropes and vasopressors for FCPS Part 1. Explains adrenaline's dose effects, phenylephrine reflex bradycardia, glucagon in beta-blocker overdose, milrinone, levosimendan and vasopressin in shock.
Synthesis and release of catecholamines
- Tyrosine is hydroxylated to DOPA (rate-limiting, tyrosine hydroxylase), then dopamine, then noradrenaline inside vesicles (dopamine β-hydroxylase).
- Adrenaline is made from noradrenaline by PNMT in the chromaffin cells of the adrenal medulla; PNMT is induced by cortisol arriving in portal blood from the cortex. The medulla secretes about 80% adrenaline and 20% noradrenaline.
- Noradrenaline is released by postganglionic sympathetic neurons (except those to sweat glands, which release ACh). It is removed mainly by reuptake (uptake 1, blocked by cocaine and tricyclics) and then metabolised by MAO and COMT.
- Reserpine blocks the vesicular monoamine transporter (VMAT), so noradrenaline, dopamine and serotonin leak out and are destroyed; stores deplete, blood pressure falls and severe depression follows. Tetrabenazine, used for chorea, shares this action.
Adrenergic receptors
| Receptor | G protein and messenger | Main effects |
|---|---|---|
| α1 | Gq; IP3 and Ca2+ | Vasoconstriction, mydriasis (dilator pupillae), bladder neck and prostate contraction, Müller muscle of the eyelid |
| α2 | Gi; falls in cAMP | Presynaptic inhibition of noradrenaline release, reduced central sympathetic outflow, reduced insulin and aqueous humour secretion |
| β1 | Gs; rise in cAMP | Heart rate, contractility and AV conduction increase; renin release |
| β2 | Gs; rise in cAMP | Bronchodilatation, vasodilatation in muscle, uterine relaxation, glycogenolysis, K+ shift into cells, tremor, mast cell stabilisation |
| β3 | Gs | Lipolysis, detrusor relaxation (mirabegron) |
| D1 | Gs | Renal and mesenteric vasodilatation |
- Salbutamol stimulates β2 receptors, raising cAMP, which activates protein kinase A, lowers intracellular calcium and inactivates myosin light-chain kinase: the bronchial muscle relaxes. It also stimulates Na+/K+-ATPase, so overuse causes hypokalaemia and nebulised salbutamol treats hyperkalaemia.
- Adrenaline and glucagon both raise blood glucose through cAMP: hepatic glycogenolysis and gluconeogenesis. Adrenaline also suppresses insulin (α2) and stimulates lipolysis.
Adrenaline: effects depend on dose
| Dose | Dominant receptors | Blood pressure and heart |
|---|---|---|
| Low (infusion in a healthy subject) | β1 and β2 | Systolic rises, diastolic falls (β2 vasodilatation in muscle), mean pressure little changed, heart rate rises |
| High | α1 dominant | Systolic and diastolic both rise; reflex slowing may appear |
- Anaphylaxis: 0.5 mg IM (1 mg/mL) into the anterolateral thigh. It works by α1 vasoconstriction, β1 cardiac support, β2 bronchodilatation and a β2-mediated rise in mast cell cAMP that limits further histamine release. Patients on β-blockers respond poorly; glucagon can help.
- Cardiac arrest: 1 mg IV (0.1 mg/mL).
- Croup: nebulised adrenaline gives rapid relief by α1 vasoconstriction of the subglottic mucosa, shrinking oedema. The effect wears off in 2 hours, so observe before discharge.
- With local anaesthetic: vasoconstriction slows absorption, prolongs the block, reduces bleeding and allows a higher maximum dose (lidocaine about 3 mg/kg plain, 7 mg/kg with adrenaline).
- Halothane sensitises the myocardium to catecholamines; infiltrating large volumes of adrenaline under halothane causes ventricular ectopics and tachycardia. Lidocaine itself is not the culprit.
- Lactate rise on adrenaline in sepsis, with improving perfusion, is caused by β2-driven aerobic glycolysis in skeletal muscle (with hyperglycaemia), not by hypoperfusion.
Other sympathomimetics
| Drug | Receptors | Uses and notes |
|---|---|---|
| Noradrenaline | α1 more than β1, little β2 | First-line vasopressor in septic shock; raises both pressures; reflex bradycardia; extravasation necrosis (phentolamine) |
| Dopamine | Low dose D1, medium β1, high α1 | Shock (arrhythmias limit use); "renal dose" has no proven kidney benefit |
| Dobutamine | β1 (some β2) | Inotrope for cardiogenic shock; stress echocardiography; may lower BP |
| Isoprenaline | β1, β2 | Bradycardia, heart block (bridge to pacing) |
| Phenylephrine | Pure α1 | Spinal hypotension, nasal decongestant, mydriatic |
| Ephedrine | Indirect (releases NA) plus direct | Spinal hypotension; tachyphylaxis |
| Metaraminol | Mainly α1 | Anaesthetic hypotension |
| Midodrine | Oral prodrug, α1 | Orthostatic hypotension; causes supine hypertension, so last dose well before bedtime |
| Xylometazoline, oxymetazoline | α agonists | Nasal decongestion; more than a week of use causes rhinitis medicamentosa (rebound congestion) |
| Salbutamol, terbutaline | β2 | Asthma, hyperkalaemia |
| Salmeterol, formoterol | Long-acting β2 | Asthma (always with inhaled steroid), COPD |
| Clonidine | Central α2 | Hypertension, opioid withdrawal; rebound hypertension on abrupt withdrawal |
| Moxonidine | Imidazoline I1 in the medulla | Hypertension; less sedation and dry mouth than clonidine; avoid in heart failure |
| Methyldopa | α2 via α-methylnoradrenaline | Hypertension in pregnancy; positive DAT, hepatitis, depression |
| Apraclonidine, brimonidine | α2 | Glaucoma |
| Amphetamine, tyramine | Indirect (release NA) | Hypertensive crisis with MAO inhibitors |
| Cocaine | Blocks NA reuptake | Vasoconstriction, MI; avoid β-blocker alone |
- Phenylephrine raises blood pressure and the baroreceptor reflex slows the heart. Ephedrine raises both pressure and heart rate because it also acts on β1.
- Ephedrine with an MAO inhibitor (phenelzine): nerve endings are loaded with noradrenaline that MAO has not destroyed, so the indirect agent releases an excess of stored noradrenaline, causing a hypertensive crisis. Use a direct agent in small doses.
- Methyldopa induces IgG red cell autoantibodies in up to 20% of users: a positive direct antiglobulin test, usually without haemolysis. Change it after delivery because it can worsen postnatal depression.
- Apraclonidine test for Horner syndrome: the sympathetically denervated dilator pupillae and Müller muscle develop α1 denervation supersensitivity, so the weak α1 action of apraclonidine dilates the small pupil and lifts the ptosis. It may be negative in very recent Horner syndrome.
Inotropes and vasopressors in shock
| Situation | Drug and reason |
|---|---|
| Septic shock | Noradrenaline after fluids, target MAP 65 mmHg; add vasopressin; adrenaline; hydrocortisone if refractory |
| Cardiogenic shock | Dobutamine (plus noradrenaline if hypotensive) |
| Low output in a β-blocked patient | Milrinone: PDE3 inhibitor; cAMP rises without needing β-receptors; inodilator; renally cleared |
| Low output after cardiac surgery | Levosimendan: sensitises troponin C to calcium and opens vascular K-ATP channels; can cause hypotension |
| Anaphylaxis | IM adrenaline |
| Symptomatic bradycardia | Atropine, then isoprenaline or adrenaline infusion, pacing |
- Vasopressin works when catecholamines fail because septic shock produces a relative vasopressin deficiency and V1 receptors still respond in acidosis. It is a catecholamine-sparing add-on, not first line.
- Vasopressors are given through a central line where possible.
α-blockers
| Drug | Notes |
|---|---|
| Phenoxybenzamine | Irreversible, non-selective; phaeochromocytoma before surgery (α-blockade before β-blockade) |
| Phentolamine | Reversible; hypertensive crisis in phaeochromocytoma or MAOI reactions; noradrenaline extravasation |
| Prazosin, doxazosin | α1-selective; hypertension, BPH; first-dose hypotension; prazosin is the mainstay for scorpion sting (venom causes massive catecholamine release with hypertension, pulmonary oedema and priapism) |
| Tamsulosin | α1A (prostate); BPH, ureteric stone expulsion; floppy iris during cataract surgery |
Exam trap Do not give atropine for the sweating and salivation of a scorpion sting; it worsens the tachycardia and hypertension.
β-blockers
| Drug | Features |
|---|---|
| Propranolol | Non-selective, lipid-soluble; thyrotoxicosis, tremor, migraine, anxiety, portal hypertension, infantile haemangioma |
| Atenolol, bisoprolol, metoprolol | β1-selective; safer (not safe) in COPD |
| Bisoprolol, carvedilol, metoprolol succinate, nebivolol | Reduce mortality in heart failure |
| Labetalol | α and β; pregnancy hypertension, emergencies |
| Esmolol | Half-life about 9 minutes (red cell esterases); perioperative tachycardia, dissection |
| Sotalol | Also class III (long QT) |
| Timolol | Glaucoma: reduces aqueous production; can cause bronchospasm |
| Pindolol, acebutolol | Intrinsic sympathomimetic activity: less bradycardia |
- Side effects: bronchospasm, bradycardia, prolonged PR interval (slowed AV nodal conduction), heart block, cold peripheries, fatigue, nightmares, erectile dysfunction.
- In an insulin-treated diabetic, propranolol masks the warning signs of hypoglycaemia (tremor, palpitations; sweating is cholinergic and persists) and delays recovery by blocking glycogenolysis.
- Contraindications: asthma, second- or third-degree block, acute decompensated heart failure, IV verapamil, cocaine toxicity.
- β-blocker overdose with bradycardia and hypotension resistant to atropine and fluids: glucagon. It acts on its own Gs-coupled receptor in the myocardium, raising cAMP independently of β-receptors. High-dose insulin euglycaemia therapy is also used.
Remember Glucagon and milrinone both raise cardiac cAMP by bypassing the blocked β-receptor.
The cholinergic side at a glance
This chapter shares questions with the cholinergic chapter; the key facts are:
| Problem | Drug and principle |
|---|---|
| Organophosphate poisoning | Atropine until the chest is clear (the best sign of adequate dosing) plus early pralidoxime before the enzyme ages; weakness on day 2–4 with neck flexor weakness and falling vital capacity is the intermediate syndrome |
| Reversal of rocuronium | Neostigmine with glycopyrrolate (blocks muscarinic side effects) |
| Rising pyridostigmine with sweating, miosis, fasciculation | Cholinergic crisis |
| Myasthenia maintenance | Pyridostigmine; cramps and diarrhoea; edrophonium (very short-acting) was the diagnostic test |
| Child hot, dry, flushed, delirious after berries | Physostigmine; fever because sweat glands are muscarinic |
| Motion sickness patch | Hyoscine hydrobromide, not butylbromide |
| Post-operative non-obstructive retention | Bethanechol |
| Dry mouth in Sjögren syndrome | Oral pilocarpine |
| Death rattle without sedation; bladder drug in dementia | Glycopyrronium; trospium (both quaternary) |
| Cycloplegic refraction in a child | Cyclopentolate 1% |
| Painful red eye after nebulised ipratropium | Angle closure from mist reaching the eye |
| Heart slows after 0.1 mg atropine | Too small a dose causes paradoxical bradycardia |
Exam trap In phaeochromocytoma, give α-blockade first; β-blockade alone leaves α1 vasoconstriction unopposed.
How FCPS asks about this
- Low-dose adrenaline in a volunteer: systolic up, diastolic down (β2 vasodilatation).
- Heart slows after phenylephrine: baroreceptor reflex; ephedrine raises both pressure and rate.
- β-blocker overdose resistant to atropine: glucagon, acting via its own Gs receptor.
- Milrinone mechanism: PDE3 inhibition raises cAMP; levosimendan sensitises troponin C.
- First vasopressor in septic shock and MAP target: noradrenaline, 65 mmHg; vasopressin works through relative deficiency.
- Why adrenaline is added to lidocaine: slows absorption, prolongs action, raises the maximum dose.
- Salbutamol and electrolytes: hypokalaemia; β2 raises cAMP to relax bronchi.
Test yourself on this topic
5 of the 108 questions in our bank on this topic. Choose an answer to see why every option is right or wrong.
After spinal anaesthesia for TURP, a 70-year-old man has a BP of 82/50 mmHg and a pulse of 50/min. Which vasopressor is most suitable?
Answer: Ephedrine
A high spinal block causes vasodilatation and, if it reaches T1–T4, blocks the cardiac accelerator fibres, giving hypotension with bradycardia. Ephedrine acts directly on α and β receptors and indirectly by releasing noradrenaline, so it raises both heart rate and blood pressure. Pure α-agonists such as phenylephrine and metaraminol raise pressure but slow the heart further by the baroreflex. Ephedrine is given in small IV boluses.
Ephedrine
- Direct + indirect sympathomimetic
- Raises HR and BP
- Use when hypotension + bradycardia
- Repeated doses: tachyphylaxis
Remember Slow and low: ephedrine.
Exam trap Atropine alone corrects the rate but does little for the vasodilatation.
Why the other options are wrong
- Phenylephrine Pure α1-agonist; reflex bradycardia would worsen the slow pulse.
- Metaraminol Mainly α action; also slows the heart reflexly.
- Vasopressin Not a first-line bolus agent for spinal hypotension.
- Noradrenaline An infusion agent; not ideal for a quick bolus in theatre.
A man with cirrhosis and large oesophageal varices that have not bled is started on propranolol. Why is a non-selective β-blocker used rather than a β1-selective drug?
Answer: β2 block leaves splanchnic α tone unopposed
Non-selective β-blockers lower portal pressure in two ways. β1 blockade reduces heart rate and cardiac output, and therefore splanchnic inflow. β2 blockade removes β2-mediated vasodilatation in the splanchnic arterioles, leaving α-adrenergic vasoconstriction unopposed and further reducing portal inflow. A β1-selective drug provides only the first effect. Carvedilol, which adds α1 blockade, is also used.
β-blockers for varices
- β1 block: lower cardiac output
- β2 block: unopposed α splanchnic constriction
- Less portal inflow, lower pressure
- Propranolol, nadolol, carvedilol
Remember Varices need both β1 and β2 blocked.
Exam trap Stop or reduce β-blockers in refractory ascites with hypotension or AKI.
Why the other options are wrong
- β1 block alone raises portal pressure β1 blockade lowers cardiac output and portal inflow.
- Propranolol is a direct venodilator Propranolol is not a venodilator.
- β1-selective drugs cause variceal bleeding They do not cause bleeding; they are simply less effective.
- Only propranolol is cleared by the liver Liver clearance is not the reason for the choice.
A peripheral cannula delivering noradrenaline in ICU has extravasated. The skin around the site is white, cold and painful. Which drug should be infiltrated locally to prevent necrosis?
Answer: Phentolamine
Noradrenaline is a potent α1 agonist. When it leaks into the tissues it causes intense local vasoconstriction, blanching and ischaemic necrosis of the skin. Phentolamine is a short-acting, competitive, non-selective α-blocker (α1 and α2); infiltrated through the area it reverses the vasoconstriction and restores blood flow. It is also used for hypertensive crises from catecholamine excess (phaeochromocytoma, cocaine, the cheese reaction with MAO inhibitors) and to reverse adrenaline-containing local anaesthetic. Phenoxybenzamine, in contrast, is an irreversible (covalent) α-blocker used before phaeochromocytoma surgery. Vasopressors are best given through a central line for this reason.
α-blockers
- Phentolamine: reversible, short-acting, non-selective
- Uses: vasopressor extravasation, catecholamine crises
- Phenoxybenzamine: irreversible; pre-op phaeochromocytoma
- α1-selective (doxazosin, tamsulosin): BPH, hypertension
Remember Phentolamine undoes the white patch from leaking noradrenaline.
Exam trap Never use a β-blocker alone when catecholamines are in excess; unopposed α action makes things worse.
Why the other options are wrong
- Propranolol β-blockade would leave α vasoconstriction unopposed.
- Atropine Atropine blocks muscarinic receptors; it does not reverse α1 vasoconstriction.
- Hyaluronidase alone Hyaluronidase is used for some non-vasoactive extravasations, not as the antidote here.
- Adrenaline Adrenaline would worsen the vasoconstriction.
A septic patient is started on noradrenaline. MAP rises from 55 to 70 mmHg, heart rate falls slightly from 110/min, and cardiac output barely changes. Which of the following receptor profiles best explains these effects?
Answer: Strong α1, moderate β1, little β2
Noradrenaline is a potent α1 agonist with moderate β1 activity and very little β2 action. α1 vasoconstriction raises systemic vascular resistance and mean arterial pressure. The rise in pressure activates the baroreflex, which offsets the direct β1 rise in heart rate, so the rate may stay the same or fall and output changes little. This makes it the first-line vasopressor in septic shock.
Noradrenaline
- α1 >> β1, minimal β2
- SVR and MAP rise
- Baroreflex offsets β1 tachycardia
- First-line in septic shock
Remember Noradrenaline squeezes vessels.
Exam trap Give it through a central line where possible; extravasation causes tissue necrosis.
Why the other options are wrong
- Strong β1 and β2, little α1 This is isoprenaline.
- Mainly D1 with some β1 This is low-dose dopamine.
- Strong β2, weak α1 and β1 This resembles salbutamol.
- Equal α1, β1 and β2 at all doses No catecholamine has this profile; adrenaline is closest but is β2-dominant at low doses.
A 50-year-old woman with primary Sjögren syndrome has a very dry mouth that makes eating difficult, despite saliva substitutes. Which of the following drugs can stimulate her remaining salivary gland function?
Answer: Oral pilocarpine
Salivary secretion is driven by parasympathetic nerves acting on M3 muscarinic receptors of acinar cells. Pilocarpine is a muscarinic agonist that stimulates any surviving glandular tissue to secrete saliva (and tears) in Sjögren syndrome or after head and neck radiotherapy. Expected adverse effects are sweating, flushing, urinary frequency and diarrhoea; it is used cautiously in asthma, heart disease and narrow-angle glaucoma. Antimuscarinic drugs such as hyoscine and amitriptyline worsen dryness.
Pilocarpine
- Muscarinic (M3) agonist
- Stimulates residual salivary tissue
- Uses: Sjögren, post-radiotherapy, glaucoma
- Adverse: sweating, flushing, frequency
Remember To make a gland work, stimulate M3.
Exam trap Review the drug list first; many drugs with antimuscarinic action cause dry mouth.
Why the other options are wrong
- Oral hyoscine An antimuscarinic; makes the mouth drier.
- Amitriptyline Anticholinergic; worsens dry mouth.
- Hydroxychloroquine Helps joint and skin features, not gland dryness.
- Oral prednisolone Does not restore salivary flow in established disease.
Where this sits in the CPSP syllabus
- Paper 1: Autonomic and CNS drugs, Adrenergic agonists and blockers
- Surgery & Allied, Paper 2: Drugs in surgical practice, Inotropes and vasopressors
- Medicine & Allied, Paper 2: Systemic drugs, Autonomic drugs
Read next
Drug dose pages
Doses, cautions and practical tips for drugs in this chapter.